Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutations in the ATP-sensitive K(+) channel (KATP channel). We investigated the interactions between MgATP, MgADP, and the sulphonylurea gliclazide with KATP channels expressed in Xenopus oocytes. In the abse...
主要な著者: | Proks, P, De Wet, H, Ashcroft, F |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2013
|
類似資料
-
Phentolamine block of ATP-sensitive K+ channels does not involve interaction with the sulphonylurea receptor, SUR1.
著者:: Proks, P, 等
出版事項: (1997) -
Interaction of MgATP with the sulphonylurea subunit activates ATP sensitive K-channels receptor
著者:: Gribble, F, 等
出版事項: (1998) -
How ATP inhibits the open K(ATP) channel.
著者:: Craig, T, 等
出版事項: (2008) -
Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
著者:: Reimann, F, 等
出版事項: (2003) -
Mechanism of K-ATP channel inhibition by ATP
著者:: Ashcroft, F, 等
出版事項: (1998)